A Fresh Look at CAR T-Cell Therapy: Recent Advances, New Evidence, and Evolving Paradigms to Improve Patient Care
CAR T-Cell Therapy in Lymphomas
CAR T-Cell Therapy for Myeloma
CAR T-Cell Therapies for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)
Best Practices in Identifying and Managing CAR T-Cell–Mediated Toxicities
On demand activity expected to be available here on December 9.